Matches in Wikidata for { <http://www.wikidata.org/entity/Q61814315> ?p ?o ?g. }
- Q61814315 description "2018 թվականին հրատարակված գիտական հոդված" @default.
- Q61814315 description "article scientifique (publié 2018)" @default.
- Q61814315 description "articolo scientifico (pubblicato il 2018)" @default.
- Q61814315 description "artigo científico (publicado na 2018)" @default.
- Q61814315 description "artikull shkencor i botuar më 01 janar 2018" @default.
- Q61814315 description "artículo científico publicado en 2018" @default.
- Q61814315 description "artículu científicu espublizáu en xineru de 2018" @default.
- Q61814315 description "im Jahr 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61814315 description "scientific article published on 01 January 2018" @default.
- Q61814315 description "wetenschappelijk artikel" @default.
- Q61814315 description "наукова стаття, опублікована у 2018" @default.
- Q61814315 description "научна статия" @default.
- Q61814315 name "Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting" @default.
- Q61814315 name "Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting" @default.
- Q61814315 name "Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting" @default.
- Q61814315 type Item @default.
- Q61814315 label "Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting" @default.
- Q61814315 label "Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting" @default.
- Q61814315 label "Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting" @default.
- Q61814315 prefLabel "Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting" @default.
- Q61814315 prefLabel "Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting" @default.
- Q61814315 prefLabel "Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting" @default.
- Q61814315 P1433 Q61814315-902C08FC-1E08-43D2-94E0-207B477DE18C @default.
- Q61814315 P1476 Q61814315-8912659C-3BAB-4F4D-866B-70ED1D09421A @default.
- Q61814315 P2093 Q61814315-583F1FA9-E057-483C-9BEC-09D4912C21D1 @default.
- Q61814315 P2093 Q61814315-99FF8C83-5135-45A9-AA84-F63AA9D0824A @default.
- Q61814315 P2093 Q61814315-C166A268-A110-49A9-804D-89DC8AF6B43A @default.
- Q61814315 P2093 Q61814315-F9F2FF96-2C35-4EB0-81B7-533EFB8498F0 @default.
- Q61814315 P275 Q61814315-30bc2dc1-54cb-4d88-b35f-4d96cf2426c0 @default.
- Q61814315 P2860 Q61814315-18878DDD-A179-4D8D-81E5-40B1E4D009DF @default.
- Q61814315 P2860 Q61814315-295E953E-28F5-4E11-81D4-381427E54ADB @default.
- Q61814315 P2860 Q61814315-2E3D37AE-0FBB-4DA0-99B7-5E161A8239B7 @default.
- Q61814315 P2860 Q61814315-32AD5AA6-DD02-4AAB-98EC-85C915A70183 @default.
- Q61814315 P2860 Q61814315-32FC65D8-7719-4247-AFD0-A193A7D1075D @default.
- Q61814315 P2860 Q61814315-3CAA4FA6-1C80-40DC-B90E-D02E7CC70C7F @default.
- Q61814315 P2860 Q61814315-43A02B80-4CAE-4F63-8A25-3BB5B9DB2800 @default.
- Q61814315 P2860 Q61814315-44749BDC-F6BD-46F3-9C94-AC49774378DB @default.
- Q61814315 P2860 Q61814315-4A78F543-C51E-4B10-A11C-C92C23A43A4E @default.
- Q61814315 P2860 Q61814315-53568913-2D22-4A2A-B56A-D9CD5BC2AB59 @default.
- Q61814315 P2860 Q61814315-63768AB1-0E9F-4B24-BB87-DC8DC51D5272 @default.
- Q61814315 P2860 Q61814315-63A4B533-71BB-42D9-8A33-F09E3E3E57FE @default.
- Q61814315 P2860 Q61814315-70C11F6A-4725-4FF0-917B-CE3EBAEE06C4 @default.
- Q61814315 P2860 Q61814315-7240CA60-1C93-4556-BFF0-9B198752EF03 @default.
- Q61814315 P2860 Q61814315-8547BB3F-F873-4112-9FDF-DB42A71B8D1C @default.
- Q61814315 P2860 Q61814315-880E4494-F66E-4603-BEF7-38CD1FCA20AD @default.
- Q61814315 P2860 Q61814315-8C62DCFF-4EA0-4A39-BB01-0E02B5AC8EC1 @default.
- Q61814315 P2860 Q61814315-A868D85C-092D-4115-9630-5202D064E701 @default.
- Q61814315 P2860 Q61814315-AD47664B-8F87-403C-AE1C-EDB21AF4E076 @default.
- Q61814315 P2860 Q61814315-B26C4253-3650-4C73-9462-D94124F6CB0D @default.
- Q61814315 P2860 Q61814315-B5002C15-50DC-4AEB-AB4D-DCF57FC94C3A @default.
- Q61814315 P2860 Q61814315-DF8D7771-5DD9-49F3-90CC-9BB3CC0278EE @default.
- Q61814315 P2860 Q61814315-E3950E5A-A0D2-479D-AD89-138173CF6AFE @default.
- Q61814315 P2860 Q61814315-F270FB9B-B4C8-4BE1-9001-ADE7AB44F764 @default.
- Q61814315 P2860 Q61814315-FC23783E-62E2-4EA7-B6B0-E2D8FCB31925 @default.
- Q61814315 P304 Q61814315-AC7D5C73-9646-4EF0-8881-E689CA46DFBF @default.
- Q61814315 P31 Q61814315-0E96B4B2-E3B9-4A6E-BD4A-372F85E657F5 @default.
- Q61814315 P356 Q61814315-55A6FE04-B278-4A96-9441-8C3671FDC8E7 @default.
- Q61814315 P407 Q61814315-F7FCC128-347A-4A78-9E3F-75B11A96D583 @default.
- Q61814315 P478 Q61814315-DAA53E61-9C25-427B-BBC9-E3CCCA6D73AA @default.
- Q61814315 P50 Q61814315-FEE3DFB9-3931-469A-995F-D2498B1F3E28 @default.
- Q61814315 P577 Q61814315-A8DD62A6-4C71-46F3-A397-234165D3434C @default.
- Q61814315 P6216 Q61814315-9d3609e9-b300-4e7e-af6e-1130328d7d90 @default.
- Q61814315 P698 Q61814315-C62C7463-9E03-481D-ADD2-B8D781B8DA35 @default.
- Q61814315 P921 Q61814315-0BB4AB5D-40E5-4AFC-BA68-832115B79A44 @default.
- Q61814315 P921 Q61814315-42492C20-D95B-4984-A330-7EED0FD762FC @default.
- Q61814315 P932 Q61814315-AE9ECC08-7CFA-40A0-B0EC-8F77AE5357B8 @default.
- Q61814315 P356 FONC.2018.00642 @default.
- Q61814315 P698 30705874 @default.
- Q61814315 P1433 Q26839986 @default.
- Q61814315 P1476 "Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting" @default.
- Q61814315 P2093 "Chang Wook Jeong" @default.
- Q61814315 P2093 "Cheol Kwak" @default.
- Q61814315 P2093 "Hyeon Hoe Kim" @default.
- Q61814315 P2093 "Ja Hyeon Ku" @default.
- Q61814315 P275 Q20007257 @default.
- Q61814315 P2860 Q26744756 @default.
- Q61814315 P2860 Q26765951 @default.
- Q61814315 P2860 Q26852084 @default.
- Q61814315 P2860 Q27861047 @default.
- Q61814315 P2860 Q27861048 @default.
- Q61814315 P2860 Q28036756 @default.
- Q61814315 P2860 Q33994334 @default.
- Q61814315 P2860 Q36025464 @default.
- Q61814315 P2860 Q36614306 @default.
- Q61814315 P2860 Q36997480 @default.
- Q61814315 P2860 Q37706516 @default.
- Q61814315 P2860 Q38033265 @default.
- Q61814315 P2860 Q38195977 @default.
- Q61814315 P2860 Q45284717 @default.
- Q61814315 P2860 Q49572921 @default.
- Q61814315 P2860 Q51064514 @default.
- Q61814315 P2860 Q51487533 @default.
- Q61814315 P2860 Q53110548 @default.
- Q61814315 P2860 Q67524173 @default.
- Q61814315 P2860 Q71842951 @default.
- Q61814315 P2860 Q78844194 @default.
- Q61814315 P2860 Q81547801 @default.
- Q61814315 P2860 Q83737518 @default.
- Q61814315 P2860 Q83739138 @default.
- Q61814315 P2860 Q87711943 @default.